Search
Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis
Abstract
Psoriasis is a systemic disease that is strictly connected with metabolic disorders (insulin resistance, atherogenic dyslipidemia, arterial hypertension, and cardiovascular diseases). It occurs more often in patients with a more severe course of the disease. Obesity is specially an independent risk factor and it is associated with a worse treatment outcome because of the high inflammatory activity of visceral fatty tissue and the production of inflammatory me - diators involved in the development of both psoriasis and metabolic disorders. However, in psoriasis the activation of the Th17/IL-17 and the abnormalities in the Th17/Treg balance axis are observed, but this pathomechanism does not fully explain the frequent occurrence of metabolic disorders. Therefore, there is a need to look for better biomarkers in the diagnosis, prognosis and monitoring of concomitant disorders and therapeutic effects in psoriasis. In addition, the education on the use of a proper diet as a prophylaxis for the development of the above disorders is an important element of holistic care for a patient with psoriasis. Diet may affect gene expression due to epigenetic modification which encompasses interactions of environment, nutrition and diseases. Patients with psoriasis should be advised to adopt proper diet and dietician support.
Citations
-
2 7
CrossRef
-
0
Web of Science
-
2 7
Scopus
Authors (25)
-
Agnieszka Owczarczyk-Saczonek
-
Dorota Purzycka-Bohdan
-
Bogusław Nedoszytko
-
Adam Reich
-
Aneta Szczerkowska-Dobosz
-
Joanna Bartosińska
-
Aleksandra Batycka-Baran
-
Rafał Czajkowski
-
Iwona T. Dobrucki
-
Lawrence W. Dobrucki
-
Magdalena Górecka-Sokołowska
-
Anna Janaszak-Jasiecka
-
Dorota Krasowska
-
Adrianna Radulska
-
Edyta Reszka
-
Dominik Samotij
-
Andrzej Słominski
-
Radomir Słominski
-
Marta Sobalska-Kwapis
-
Marta Stawczyk-Macieja
-
Dominik Strapagiel
-
Justyna Szczęch
-
Michał Żmijewski
-
Roman J. Nowicki
Cite as
Full text
- Publication version
- Accepted or Published Version
- DOI:
- Digital Object Identifier (open in new tab) 10.5114/ada.2020.98284
- License
-
open in new tab
Keywords
Details
- Category:
- Articles
- Type:
- artykuły w czasopismach
- Published in:
-
Postępy Dermatologii i Alergologii
no. 37,
pages 452 - 467,
ISSN: 1642-395X - Language:
- English
- Publication year:
- 2020
- Bibliographic description:
- Owczarczyk-Saczonek A., Purzycka-Bohdan D., Nedoszytko B., Reich A., Szczerkowska-Dobosz A., Bartosińska J., Batycka-Baran A., Czajkowski R., Dobrucki I., Dobrucki L., Górecka-Sokołowska M., Janaszak-Jasiecka A., Kalinowski L., Krasowska D., Radulska A., Reszka E., Samotij D., Słominski A., Słominski R., Sobalska-Kwapis M., Stawczyk-Macieja M., Strapagiel D., Szczęch J., Żmijewski M., Nowicki R.: Pathogenesis of psoriasis in the “omic” era. Part III. Metabolic disorders, metabolomics, nutrigenomics in psoriasis// Postępy Dermatologii i Alergologii -Vol. 37,iss. 4 (2020), s.452-467
- DOI:
- Digital Object Identifier (open in new tab) 10.5114/ada.2020.98284
- Verified by:
- Gdańsk University of Technology
seen 108 times
Recommended for you
Proteomic and Metabolomic Changes in Psoriasis Preclinical and Clinical Aspects
- A. Radulska,
- I. Pelikant-Malecka,
- K. Jendernalik
- + 2 authors
Significance of selected inflammatory factors in metabolic disorders in association with psoriasis
- P. Kiluk,
- A. Baran,
- I. Flisiak
Adipokine and cytokine levels in patients with adrenocortical cancer, subclinical Cushing's syndrome and healthy controls
- A. Babinska,
- M. F. Kaszubowski,
- P. Kmieć
- + 1 authors
Searching for the primary metabolic alterations of polycystic ovary syndrome by application of the untargeted metabolomics approach
- A. Rajska,
- M. Buszewska-Forajta,
- S. Macioszek
- + 6 authors